Please assess the completion status of the following clinical trial:

Trial Title: STAT3 in T Cells: At The Crossroads of Inflammation and Cancer

Study Design Characteristics:
- Allocation: None
- Intervention Model: None
- Observational Model: CASE_ONLY
- Primary Purpose: None
- Time Perspective: PROSPECTIVE
- Masking: None
- Phase: None
- Number of Arms: None

Eligibility Criteria:
Inclusion Criteria:~* Adult patients with CTCL that are starting new form of treatment and adult patients with benign dermatoses.~Exclusion Criteria:~* patients with lymphomas other than CTCL or leukemia

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Based on this trial design, predict the completion outcome and termination type (if applicable).